Literature DB >> 23153151

Hepatitis C testing, infection, and linkage to care among racial and ethnic minorities in the United States, 2009-2010.

Rania A Tohme1, Jian Xing, Youlian Liao, Scott D Holmberg.   

Abstract

OBJECTIVES: We estimated rates and determinants of hepatitis C virus (HCV) testing, infection, and linkage to care among US racial/ethnic minorities.
METHODS: We analyzed the Racial and Ethnic Approaches to Community Health Across the US Risk Factor Survey conducted in 2009-2010 (n = 53,896 minority adults).
RESULTS: Overall, 19% of respondents were tested for HCV. Only 60% of those reporting a risk factor were tested, with much lower rates among Asians reporting injection drug use (40%). Odds of HCV testing decreased with age and increased with higher education. Of those tested, 8.3% reported HCV infection. Respondents with income of $75,000 or more were less likely to report HCV infection than those with income less than $25,000. College-educated non-Hispanic Blacks and Asians had lower odds of HCV infection than those who did not finish high school. Of those infected, 44.4% were currently being followed by a physician, and 41.9% had taken HCV medications.
CONCLUSIONS: HCV testing and linkage to care among racial/ethnic minorities are suboptimal, particularly among those reporting HCV risk factors. Socioeconomic factors were significant determinants of HCV testing, infection, and access to care. Future HCV testing and prevention activities should be directed toward racial/ethnic minorities, particularly those of low socioeconomic status.

Entities:  

Mesh:

Year:  2012        PMID: 23153151      PMCID: PMC3518337          DOI: 10.2105/AJPH.2012.300858

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  27 in total

1.  African Americans may differ in their reasons for declining hepatitis C therapy compared to non-African Americans.

Authors:  Marie L Borum; Enaruna Igiehon; Shervin Shafa
Journal:  Dig Dis Sci       Date:  2009-04-28       Impact factor: 3.199

Review 2.  Latinos and chronic hepatitis C: a singular population.

Authors:  Maribel Rodríguez-Torres
Journal:  Clin Gastroenterol Hepatol       Date:  2008-05       Impact factor: 11.382

3.  Early treatment improves outcomes in acute hepatitis C virus infection: a meta-analysis.

Authors:  K E Corey; J Mendez-Navarro; E C Gorospe; H Zheng; R T Chung
Journal:  J Viral Hepat       Date:  2009-08-06       Impact factor: 3.728

4.  Racial differences in hepatitis C treatment eligibility.

Authors:  Michael T Melia; Andrew J Muir; Jonathan McCone; Mitchell L Shiffman; John W King; Steven K Herrine; Greg W Galler; Joseph R Bloomer; Frederick A Nunes; Kimberly A Brown; Kevin D Mullen; Natarajan Ravendhran; Reem H Ghalib; Navdeep Boparai; Ruiyun Jiang; Stephanie Noviello; Clifford A Brass; Janice K Albrecht; John G McHutchison; Mark S Sulkowski
Journal:  Hepatology       Date:  2011-07       Impact factor: 17.425

5.  Hepatitis B and hepatitis C prevalence and treatment referral among Asian Americans undergoing community-based hepatitis screening.

Authors:  Jessica P Hwang; Mahfam Mohseni; Beverly J Gor; Sijin Wen; Heather Guerrero; John M Vierling
Journal:  Am J Public Health       Date:  2010-02-10       Impact factor: 9.308

6.  Forecasting the morbidity and mortality associated with prevalent cases of pre-cirrhotic chronic hepatitis C in the United States.

Authors:  David B Rein; John S Wittenborn; Cindy M Weinbaum; Miriam Sabin; Bryce D Smith; Sarah B Lesesne
Journal:  Dig Liver Dis       Date:  2010-06-17       Impact factor: 4.088

7.  Insurance status and treatment candidacy of hepatitis C patients: analysis of population-based data from the United States.

Authors:  Maria Stepanova; Fasiha Kanwal; Hashem B El-Serag; Zobair M Younossi
Journal:  Hepatology       Date:  2011-02-11       Impact factor: 17.425

8.  Surveillance of health status in minority communities - Racial and Ethnic Approaches to Community Health Across the U.S. (REACH U.S.) Risk Factor Survey, United States, 2009.

Authors:  Youlian Liao; David Bang; Shannon Cosgrove; Rick Dulin; Zachery Harris; April Taylor; Shannon White; Graydon Yatabe; Leandris Liburd; Wayne Giles
Journal:  MMWR Surveill Summ       Date:  2011-05-20

9.  Risk factors for chronic liver disease in Blacks, Mexican Americans, and Whites in the United States: results from NHANES IV, 1999-2004.

Authors:  Yvonne N Flores; Hal F Yee; Mei Leng; José J Escarce; Roshan Bastani; Jorge Salmerón; Leo S Morales
Journal:  Am J Gastroenterol       Date:  2008-07-30       Impact factor: 10.864

10.  Economic evaluation of early monotherapy versus delayed monotherapy or combination therapy in patients with acute hepatitis C in Germany.

Authors:  Charalabos-Markos Dintsios; Alexander Haverkamp; Johannes Wiegand; Tilman Gerlach; Heiner Wedemeyer; Gerd Pape; Michael Peter Manns; Christian Krauth
Journal:  Eur J Gastroenterol Hepatol       Date:  2010-03       Impact factor: 2.566

View more
  30 in total

1.  Hepatitis C-Related Mortality Among American Indian/Alaska Native Persons in the Northwestern United States, 2006-2012.

Authors:  Sarah M Hatcher; Sujata Joshi; Byron F Robinson; Thomas Weiser
Journal:  Public Health Rep       Date:  2019-11-25       Impact factor: 2.792

2.  Cigarette Smoking in Persons Living with Hepatitis C: The National Health and Nutrition Examination Survey (NHANES), 1999-2014.

Authors:  Ryung S Kim; Andrea H Weinberger; Geetanjali Chander; Mark S Sulkowski; Brianna Norton; Jonathan Shuter
Journal:  Am J Med       Date:  2018-01-31       Impact factor: 4.965

3.  Integrating Routine HCV Testing in Primary Care: Lessons Learned from Five Federally Qualified Health Centers in Philadelphia, Pennsylvania, 2012-2014.

Authors:  Catelyn Coyle; Helena Kwakwa; Kendra Viner
Journal:  Public Health Rep       Date:  2016 May-Jun       Impact factor: 2.792

4.  Incorporation of Social Determinants of Health in the Peer-Reviewed Literature: A Systematic Review of Articles Authored by the National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention.

Authors:  Eleanor E Friedman; Hazel D Dean; Wayne A Duffus
Journal:  Public Health Rep       Date:  2018-06-06       Impact factor: 2.792

5.  Neighborhood Inequalities in Hepatitis C Mortality: Spatial and Temporal Patterns and Associated Factors.

Authors:  Mary M Ford; Payal S Desai; Gil Maduro; Fabienne Laraque
Journal:  J Urban Health       Date:  2017-10       Impact factor: 3.671

6.  Incidence of marginal zone lymphoma in the United States, 2001-2009 with a focus on primary anatomic site.

Authors:  Mohammad O Khalil; Lindsay M Morton; Susan S Devesa; David P Check; Rochelle E Curtis; Dennis D Weisenburger; Graça M Dores
Journal:  Br J Haematol       Date:  2014-01-12       Impact factor: 6.998

7.  Results from a Geographically Focused, Community-Based HCV Screening, Linkage-to-Care and Patient Navigation Program.

Authors:  Stacey B Trooskin; Joanna Poceta; Caitlin M Towey; Annajane Yolken; Jennifer S Rose; Najia L Luqman; Ta-Wanda L Preston; Philip A Chan; Curt Beckwith; Sophie C Feller; Hwajin Lee; Amy S Nunn
Journal:  J Gen Intern Med       Date:  2015-02-14       Impact factor: 5.128

8.  Hepatitis C Infection Among Hispanics in California.

Authors:  Catherine A Cummins; Erlyana Erlyana; Dennis G Fisher; Grace L Reynolds
Journal:  J Addict Dis       Date:  2015

9.  Racial disparity in all-cause mortality among hepatitis C virus-infected individuals in a general US population, NHANES III.

Authors:  B Emmanuel; M D Shardell; L Tracy; S Kottilil; S S El-Kamary
Journal:  J Viral Hepat       Date:  2016-12-01       Impact factor: 3.728

10.  An Electronic Health Record-based Intervention to Promote Hepatitis C Virus Testing Among Adults Born Between 1945 and 1965: A Cluster-randomized Trial.

Authors:  Alex D Federman; Natalie Kil; Joseph Kannry; Evie Andreopolous; Wilma Toribio; Joanne Lyons; Mark Singer; Anthony Yartel; Bryce D Smith; David B Rein; Katherine Krauskopf
Journal:  Med Care       Date:  2017-06       Impact factor: 2.983

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.